Medline Q2 Adj. EPS $0.50 Beats $0.32 Estimate, Sales $7.685B Beat $7.512B Estimate
Medline (NASDAQ:MDLN) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.32 by 56.25 percent. The company reported quarterly sales of $7.685 billion which beat the analyst
Medline made more money than experts thought it would—both from selling stuff and from profits. When a company beats what people expected, it can mean the business is running really well, which is worth noticing.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.